Skip to main content
logo
NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.5000
+0.0984 (24.50%)
Sep 4, 2026, 3:55 PM EDT - Market open

NeuroSense Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
182328111426
Market Cap Growth
-29.02%-17.70%158.68%-24.68%-46.24%-
Enterprise Value
1822276625
Last Close Price
0.400.771.200.791.222.46

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
--14.6410.74-6.102.442.94
P/TBV Ratio
--10.74-2.442.94

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.11-0.110.03-0.080.04-
Net Debt / Equity Ratio
0.000.00-1.281.42-1.18-1.23
Net Debt / EBITDA Ratio
000.340.210.653.71
Net Debt / FCF Ratio
0.000.000.330.300.907.11
Quick Ratio
0.080.081.780.814.1818.83
Current Ratio
0.310.312.210.844.2819.12
Return on Equity (ROE)
-2174.97%-2174.97%-2478.15%-494.83%-141.31%-66.63%
Return on Assets (ROA)
-247.30%-247.30%-159.50%-138.15%-68.90%-30.56%
Return on Capital Employed (ROCE)
745.00%745.00%-383.40%4397.40%-176.20%-27.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-74.92%-48.71%-36.79%-94.21%-73.67%-12.16%
FCF Yield
-51.72%-33.62%-36.53%-78.14%-53.97%-5.87%
Buyback Yield / Dilution
-36.98%-36.98%-36.38%-18.56%-84.27%-13.13%
SEC Filings: 10-K · 10-Q